These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 17201665

  • 21. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.
    Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD.
    J Virol; 1993 Dec; 67(12):7522-32. PubMed ID: 7693974
    [Abstract] [Full Text] [Related]

  • 22. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus.
    Bruña-Romero O, Lasarte JJ, Wilkinson G, Grace K, Clarke B, Borrás-Cuesta F, Prieto J.
    Hepatology; 1997 Feb; 25(2):470-7. PubMed ID: 9021966
    [Abstract] [Full Text] [Related]

  • 23. Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.
    Polakos NK, Drane D, Cox J, Ng P, Selby MJ, Chien D, O'Hagan DT, Houghton M, Paliard X.
    J Immunol; 2001 Mar 01; 166(5):3589-98. PubMed ID: 11207320
    [Abstract] [Full Text] [Related]

  • 24. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA, Sherritt MA, Medveczky J, Elliott SL, Moss DJ, Fernando GJ, Brown LE, Suhrbier A.
    J Immunol; 1998 Feb 15; 160(4):1717-23. PubMed ID: 9469429
    [Abstract] [Full Text] [Related]

  • 25. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
    Ishioka GY, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, del Guercio MF, Oseroff C, Dahlberg C, Alexander J, Chesnut RW, Sette A.
    J Immunol; 1999 Apr 01; 162(7):3915-25. PubMed ID: 10201910
    [Abstract] [Full Text] [Related]

  • 26. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.
    Fonseca DP, Benaissa-Trouw B, van Engelen M, Kraaijeveld CA, Snippe H, Verheul AF.
    Infect Immun; 2001 Aug 01; 69(8):4839-45. PubMed ID: 11447158
    [Abstract] [Full Text] [Related]

  • 27. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM, Bonneau RH, Epler M, Tevethia MJ, Alam S, Verner K, Tevethia SS.
    Virology; 1996 Aug 01; 222(1):269-74. PubMed ID: 8806508
    [Abstract] [Full Text] [Related]

  • 28. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
    Xu W, Chu Y, Zhang R, Xu H, Wang Y, Xiong S.
    Virology; 2005 Apr 10; 334(2):255-63. PubMed ID: 15780875
    [Abstract] [Full Text] [Related]

  • 29. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
    Geissler M, Gesien A, Tokushige K, Wands JR.
    J Immunol; 1997 Feb 01; 158(3):1231-7. PubMed ID: 9013964
    [Abstract] [Full Text] [Related]

  • 30. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.
    Shirai M, Okada H, Nishioka M, Akatsuka T, Wychowski C, Houghten R, Pendleton CD, Feinstone SM, Berzofsky JA.
    J Virol; 1994 May 01; 68(5):3334-42. PubMed ID: 7512163
    [Abstract] [Full Text] [Related]

  • 31. Construction of, and T-helper (Th)1/Th2 immune responses to, a herpes simplex virus type 2 glycoprotein D-cytotoxic T-lymphocyte epitope DNA vaccine.
    Huilan Y, Cui Z, Jianyong F, Lei G, Wei Q.
    Clin Exp Dermatol; 2010 Jul 01; 35(5):537-42. PubMed ID: 20497188
    [Abstract] [Full Text] [Related]

  • 32. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Shawky H, Maghraby AS, Solliman Mel-D, El-Mokadem MT, Sherif MM, Arafa A, Bahgat MM.
    Arch Virol; 2015 Apr 01; 160(4):945-58. PubMed ID: 25631616
    [Abstract] [Full Text] [Related]

  • 33. Comparison of antibody- and cell-mediated immune responses after intramuscular hepatitis C immunizations of BALB/c mice.
    Ghorbani M, Nass T, Azizi A, Soare C, Aucoin S, Giulivi A, Anderson DE, Diaz-Mitoma F.
    Viral Immunol; 2005 Apr 01; 18(4):637-48. PubMed ID: 16359230
    [Abstract] [Full Text] [Related]

  • 34. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
    Kuhröber A, Wild J, Pudollek HP, Chisari FV, Reimann J.
    Int Immunol; 1997 Aug 01; 9(8):1203-12. PubMed ID: 9263018
    [Abstract] [Full Text] [Related]

  • 35. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J, Grusby MJ, Schirmbeck R, Reimann J.
    J Immunol; 1999 Aug 15; 163(4):1880-7. PubMed ID: 10438922
    [Abstract] [Full Text] [Related]

  • 36. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
    Tokushige K, Wakita T, Pachuk C, Moradpour D, Weiner DB, Zurawski VR, Wands JR.
    Hepatology; 1996 Jul 15; 24(1):14-20. PubMed ID: 8707253
    [Abstract] [Full Text] [Related]

  • 37. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.
    Vidalin O, Fournillier A, Renard N, Chen M, Depla E, Boucreux D, Brinster C, Baumert T, Nakano I, Fukuda Y, Liljeström P, Trépo C, Inchauspé G.
    Virology; 2000 Oct 25; 276(2):259-70. PubMed ID: 11040118
    [Abstract] [Full Text] [Related]

  • 38. A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.
    Li X, Yang X, Jiang Y, Liu J.
    Int Immunol; 2005 Oct 25; 17(10):1293-302. PubMed ID: 16113237
    [Abstract] [Full Text] [Related]

  • 39. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.
    Schirmbeck R, Stober D, El-Kholy S, Riedl P, Reimann J.
    J Immunol; 2002 Jun 15; 168(12):6253-62. PubMed ID: 12055239
    [Abstract] [Full Text] [Related]

  • 40. Three new cytotoxic T cell epitopes identified within the hepatitis C virus nucleoprotein.
    Kaneko T, Nakamura I, Kita H, Hiroishi K, Moriyama T, Imawari M.
    J Gen Virol; 1996 Jun 15; 77 ( Pt 6)():1305-9. PubMed ID: 8683220
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.